IPO Lockup Expiration Alert: Inozyme Pharma (INZY)
IPO Lockup Expiration Alert: Inozyme Pharma (INZY) BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The lockup period of Boston, Massachusetts-based Inozyme Pharma (INZY) ends today, i.e., January 20, 2021. Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of calcification disorders of the circulatory system, bones, and kidneys. The company's lead product candidate, INZ-701, is an enzyme replacement therapy for patients with a variety of calcification disorders linked primarily to Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 or ENPP1 Deficien...